Survival of all cancer sites combined: Partitioning of temporal changes into cancer, non-cancer and case-mix
Cancer Epidemiology · 2026
DOI: 10.1016/j.canep.2026.102999 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Epidemiology, 2026. Verfasst von Paul C Lambert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; Dept Medical Epidemiology and Biostatistics, Karolinska Institutet, St…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, National Institute for Health and Care Research, NIHR Leicester Biomedical Research Centre.
Abstract (Originalsprache)
Quantifying cancer survival is a crucial component of cancer surveillance and control. Survival for all cancers combined is an overall summary to explore differences between population groups and over time. Net survival is the usual measure for reporting survival for all cancers combined. Differences in the cancer site distribution between groups can be adjusted for using standardization. We propose using individual weights incorporated into the Pohar Perme estimator of net survival for standardized all cancers combined survival estimates, rather than a weighted average of stratum specific estimates. This removes sparse data problems, where estimates are unobtainable for some strata. Extending to reference adjusted all-cause survival gives an alternative, interpretable measure, enabling partitioning of all-cause survival differences into those due to cancer site/age/sex distribution differences, other cause mortality differences and cancer mortality differences. We illustrate the methods using data on 749 889 individuals diagnosed with cancer in Norway 1986-2021. Using individual weights gives very similar estimates to traditional and model-based standardization and avoids using ad-hoc sparse data methods. Reference adjusted all-cause survival provides measures with simpler interpretation. For example, between 1986 and 1990 and 2016-2021 there was a 25.9 %age point improvement in 5-year all-cause survival. This improvement was partitioned into changes in the site/age/sex distribution (2.0), changes in other cause mortality rates (4.4) with the majority (19.6) due to improvements in cancer survival. Survival of all cancers combined is easily analyzed non-parametrically using individual weights. Reference adjusted all-cause survival gives a more interpretable measure improving understanding of differences over time/between groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; Dept Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. Electronic address: paul.lambert@fhi.no.
- Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Yngvar.Nilssen@fhi.no.
- Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway. Electronic address: Tor.Age.Myklebust@fhi.no.
- Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Bjarte.Aagnes@fhi.no.
- Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway. Electronic address: Bjorn.Moller@fhi.no.
- Division of Public Health & Epidemiology, School of Medical Sciences, University of Leicester, UK. Electronic address: mark.rutherford@leicester.ac.uk.
Förderung
- Vetenskapsrådet
- National Institute for Health and Care Research
- NIHR Leicester Biomedical Research Centre
- Swedish Cancer Society
- NIHR Imperial Biomedical Research Centre
Zitieren
APA
Lambert, P. C., Nilssen, Y., Myklebust, T. Å., Aagnes, B., Møller, B., & Rutherford, M. J. (2026). Survival of all cancer sites combined: Partitioning of temporal changes into cancer, non-cancer and case-mix. Cancer Epidemiology. https://doi.org/10.1016/j.canep.2026.102999
Vancouver
Lambert PC, Nilssen Y, Myklebust TÅ, Aagnes B, Møller B, Rutherford MJ. Survival of all cancer sites combined: Partitioning of temporal changes into cancer, non-cancer and case-mix. Cancer Epidemiology. 2026. doi:10.1016/j.canep.2026.102999
BibTeX
@article{Lambert2026,
author = {Lambert, Paul C and Nilssen, Yngvar and Myklebust, Tor Åge and Aagnes, Bjarte and Møller, Bjørn and Rutherford, Mark J},
title = {Survival of all cancer sites combined: Partitioning of temporal changes into cancer, non-cancer and case-mix},
journal = {Cancer Epidemiology},
year = {2026},
doi = {10.1016/j.canep.2026.102999}
}
EUVIMED